Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-09

FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydroxyzine pamoate (Teva Pharmaceuticals USA, Inc.). The approval indicates a labeling change and/or new indication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyzine pamoate (Hydroxyzine pamoate)

Snippet

SUPPL AP for HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE)